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Dysfunction of the right ventricle (RV) plays a crucial role in the outcome of various
cardiovascular diseases. Previous studies on RV metabolism are sparse although
evidence implies it may differ from left ventricular (LV) metabolism. Therefore, the aims
of this study were (1) to determine predictors of RV glucose uptake (GU) and free
fatty acid uptake (FFAU) and (2) to compare them to predictors of LV metabolism
in healthy middle-aged men. Altogether 28 healthy, sedentary, middle-aged (40–55
years) men were studied. Insulin-stimulated GU and fasting FFAU were measured by
positron emission tomography and RV and LV structural and functional parameters by
cardiac magnetic resonance. Several parameters related to whole-body health were also
measured. Predictors of RV and LV metabolism were determined by pairwise correlation
analysis, lasso regression models, and variable clustering using heatmap. RVGU was
most strongly predicted by age andmoderately by RV ejection fraction (EF). The strongest
determinants of RVFFAU were exercise capacity (peak oxygen uptake), resting heart
rate, LVEF, and whole-body insulin-stimulated glucose uptake rate. When considering
LV metabolism, age and RVEF were associated also with LVGU. In addition, LVGU was
strongly, and negatively, influenced by whole-body insulin-stimulated glucose uptake
rate. LVFFAU was predicted only by LVEF. This study shows that while RV and LV
metabolism have shared characteristics, they also have unique properties. Age of the
subject should be taken into account when measuring myocardial glucose utilization.
Ejection fraction is related to myocardial metabolism, and even so that RVEF may be
more closely related to GU of both ventricles and LVEF to FFAU of both ventricles, a
finding supporting the ventricular interdependence. However, only RV fatty acid utilization
associates with exercise capacity so that better physical fitness in a relatively sedentary
population is related with decreased RV fat metabolism. To conclude, this study highlights
the need for further study designed specifically on less-known RV, as the results on LV
metabolism and physiology may not be directly applicable to the RV.
Keywords: right ventricle, left ventricle, metabolism, glucose uptake, free fatty acid uptake, positron emission
tomography, magnetic resonance imaging, exercise
Abbreviations: BMI, body mass index; CMR, cardiac magnetic resonance; EDV, end-diastolic volume; EF, ejection fraction;
ESV, end-systolic volume; FDG, 2-deoxy-2-(18F)fluoro-D-glucose; FFAU, free fatty acid uptake; FTHA, 14(R,S)-(18F)fluoro-
6-thia-heptadecanoic acid; GU, glucose uptake; HR, heart rate; LV, left ventricle/ventricular; M-value, whole-body insulin-
stimulated glucose uptake; PET, positron emission tomography; RV, right ventricle/ventricular; SV, stroke volume; VO2peak,
peak oxygen consumption.
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INTRODUCTION
While the left ventricle (LV) has been studied extensively,
the right ventricle (RV) has long remained understudied
and regarded as a “passive bystander” providing merely the
pulmonary circulation (Voelkel et al., 2006; Haddad et al., 2008).
As the two ventricles are connected in series, failure in either of
the ventricles decreases cardiac output and can ultimately lead to
premature death. RV failure is a strong determinant of survival
in patients with pulmonary arterial hypertension (PAH), and its
role in the clinical outcome of various cardiovascular diseases has
been recognized (Zornoff et al., 2002; Voelkel et al., 2006; Haddad
et al., 2008; Walker and Buttrick, 2013). Cardiac metabolism
and contraction are closely integrated because without sufficient
fuel the heart is not able to fulfill the circulatory demands.
Despite of the clinically significant role of RV, studies on its basic
metabolism even in healthy subjects are scarce.
As the energy reserves of the heart are small, cardiac function
is closely tied to its capability to efficiently utilize different
substrates in order to generate ATP. Normal healthy heart
produces almost all (>95%) of its ATP through mitochondrial
oxidative phosphorylation and the remaining part through
glycolysis (Stanley et al., 2005; Lopaschuk and Kelly, 2008).
Heart is also an “omnivore,” producing most of its energy for
mitochondrial metabolism from fatty acids (60–90%) and the
remaining 10–40% from carbohydrates such as glucose and
lactate (Bing et al., 1953; van der Vusse et al., 2000). The
contribution of different energy substrates to oxidative ATP
production depends on various conditions such as alterations
in plasma substrate supply, hormonal control, workload, and
oxygen supply to the heart (Lopaschuk and Kelly, 2008; Peterson
and Gropler, 2010). Alterations of substrate utilization can be
acute adaptations to changes in physiological condition, or
chronic changes caused for example by aging, obesity, or disease
(Peterson and Gropler, 2010). For instance, RV glucose uptake
has been shown to be increased along with decreases in RV
function, such as ejection fraction (EF), in patients with PAH
(Oikawa et al., 2005; Can et al., 2011; Lundgrin et al., 2013; Yang
et al., 2014) or heart failure (Mielniczuk et al., 2011). However,
the predictors of RV metabolism in healthy heart are poorly
understood.
Therefore, the two main aims of this study were to
determine (1) predictors of RV metabolism and (2) compare
them to predictors of LV metabolism in healthy middle-aged
men. Cardiac energy substrate metabolism was measured by
determining insulin-stimulated RV and LV glucose uptake (GU)
and fasting free fatty acid uptake (FFAU) using positron emission
tomography (PET). Furthermore, cardiac magnetic resonance
(CMR), regarded as the gold standard for cardiac structural
assessment (Grothues et al., 2004), was performed to measure
RV and LV structure and function. Several parameters related
to whole-body health were also measured. Although previous
studies on RV metabolism are sparse, evidence implies that it
may differ from that of the LV as the early divergence in the
embryologic origins of the RV and LV myocardium may result
in the chamber-specific responses (Zaffran et al., 2004; Adrogue
et al., 2005; Walker and Buttrick, 2013; Sankaralingam and
Lopaschuk, 2015). We therefore hypothesized that the predictors
of RV and LV metabolism may be different.
METHODS
Subjects
The participants were recruited with advertisements in local
newspapers, through personal contacts, and using electronic
and traditional bulletin boards. Before the study, subjects were
interviewed and thoroughly examined by a medical doctor. A
candidate was accepted to the study if following criteria were
fulfilled: male sex, age 40–55 years, body mass index 18.5–
30 kg·m−2, and no exercise on regular basis (twice a week or
less, VO2peak ≤ 40ml·kg−1·min−1). A candidate was excluded
if he had a condition which could potentially endanger subject’s
health during the study or interfere with the interpretation of
the results (high blood pressure>140/90mmHg, chronic disease
or medical defect requiring medical treatment, eating disorders,
use of steroids, narcotics, tobacco, or other substrates, heavy
use of alcohol). Finally, 28 participants fulfilled the criteria.
The study was conducted according to Declaration of Helsinki,
and the study protocol was approved by the ethical committee
of the Hospital District of Southwest Finland, Turku (decision
95/180/2010§228). Written informed consent was obtained from
all subjects before the beginning of the study.
Measurements
PET Measurements
Before the PET experiments, antecubital veins from both arms
were cannulated, one for the administration of PET tracers
and other infusions (glucose-insulin clamp, only in FDG-PET
study) and the opposite one for blood sampling during the
study. The arm used for blood sampling was heated with an
electrically powered cushion for the whole duration of the study
to “arterialize” the venous blood. The subject was positioned into
the PET scanner in a supine position with the thoracic region in
the scanning area of the gantry. The PET imaging was performed
with GE Advance PET/CT scanner (General Electric Medical
System, Milwaukee, WI, USA).
FFAU was studied using 14(R,S)-(18F)fluoro-6-thia-
heptadecanoic acid (18F-FTHA) as a tracer, which is also
shown to trace the free fatty acid beta-oxidation in the heart
(Takala et al., 2002). Once the tracer [155 (SD 9) MBq] was
injected into the vein, the scanning was started immediately and
continued for 40min in 4× 15 s, 6× 20 s, 2× 60 s, 2× 150 s, and
6 × 300 s time frames. Blood samples for plasma radioactivity
determination (Wizard 1480 3; Wallac, Turku, Finland) and
the calculation of plasma input function were collected at 4, 5,
7.5, 10, 20, 30, and 40min after the injection of the tracer. The
activities of the left ventricle chamber during the first 3min (first
10 frames) were used to determine the early part of the tissue
input function. As FTHA is metabolized (Takala et al., 2002),
blood samples were analyzed at time points 5, 10, 20, 30, and
40min after the tracer injection to determine FTHA metabolites
and to correct the input function for pure plasma FTHA input
function. Free fatty acid concentrations were measured before
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FTHA-PET study and 20min after the start of the study to
calculate the final FFAU values.
On a separate day, GU was measured using 2-deoxy-2-
(18F)fluoro-D-glucose (18F-FDG). The tracer [157 (SD 10)MBq]
was injected into the vein and scanning was performed in
similar time frames as in the FTHA study. The myocardial GU
scanning was performed during euclycemic hyperinsulinemic
clamp at fasted state (explained in detail later in the text). FDG
was injected 90 (SD 16) min after the start of the euclycemic
hyperinsulinemic clamp when the subject had reached the stable
glucose concentrations at the level of 5mmol·l−1 (±0.5). Except
for the clamp, FDG-PET was performed similarly to FTHA-
PET. As FDG is not metabolized in the body (Rudroff et al.,
2015), no additional blood samples were needed for metabolite
correction. Glucose concentrations were measured at every 5min
and the whole period was used for calculations of the final GU
values.
PET Image Analysis
PET image raw files were corrected for attenuation, dead
time, and decay. Images were reconstructed using 3D-OSEM
procedure and analyzed using Carimas software (version 2.9,
www.turkupetcentre.fi/carimas). In FDG-PET images, regions of
interest (ROIs) were drawn manually to the entire RV free wall in
transaxial planes (Figure 1A). For LV, both the interventricular
septum and the entire LV free wall were included in ROIs. In
FTHA-PET images, ROIs were drawn to entire RV free wall
except for the lower border of RV to avoid spillover due to the
high tracer uptake in liver (Figure 1B). For LV, ROIs for FTHA-
PET images were drawn similarly as in FDG-PET. Once the
ROIs were manually defined, the tissue time activity curves were
extracted from dynamic PET data. Fractional tracer uptake rate
was calculated from tissue and plasma time activity curves by
using graphical analysis (Patlak et al., 1983). The rate of GU and
FFAU was calculated by multiplying the fractional tracer uptake
rate with the plasma glucose and FFA concentration during the
scanning, respectively.
BA
RV
RV
LV
LV
IVS
liver
FIGURE 1 | (A) An example of FDG-PET image in one transaxial slice. The RV
ROIs are drawn to the entire RV free wall (gray shaded voxels). The U-shaped
left ventricle is clearly seen. (B) An example of FTHA-PET image in one sagittal
slice. FTHA activity of the liver is high, and it overlaps with the RV. Therefore,
the lower border of the RV is not included in the ROI (gray shaded voxels) to
avoid cross-contamination of the signal between the tissues. Color bar shows
the tracer uptake rate with red and yellow indicating the highest uptake. RV,
right ventricle; LV, left ventricle; IVS, interventricular septum.
CMR Measurements
RV and LV structure and function was assessed by CMR using a
Philips 1.5T Gyroscan Intera CV Nova Dual MR scanner (Philips
Medical Systems, Best, The Netherlands). With the subject in
supine position, cardiac long axis, and short axis planes were
planned from localizer images. The images over the entire cardiac
cycle was obtained with cardiac cine sequencing: steady-state
free-precession cine image series were acquired with balanced
turbo field echo pulse sequence to have a stack of 10–14 parallel
slices in short axis plane and 4 slices in four-chamber plane.
The repetition time was 3.4ms, echo time 1.7ms, flip angle 60◦,
acquisition matrix 192 × 192, reconstruction matrix 256 × 256,
field of view 320–360 nm, slice thickness 6mm without gap
between slices, phases per cardiac cycle 25, and two slices per
breath-hold resulting to breath holds of 10–18 s.
CMR Image Analysis
Image analysis was performed with Philips Extended MR
WorkPlace version 2.6.3.5 (Philips Medical Systems, Best, The
Netherlands). The short axis cine images were visually inspected
to identify the end-systolic and end-diastolic phases with
the smallest and the largest ventricular cavities, respectively.
Endocardial contours were traced manually on each slice in
both end-systole and end-diastole according to the established
procedure to overcome the difficulties faced when tracing the
most basal slices especially in RV (Prakken et al., 2008). Briefly,
the contour was traced on the most basal RV end-diastolic slice
only if the trabeculations stayed visible for a minimum of three
following phases. For determination of the RV mass, epicardial
contours were traced in end-diastolic slices so that epicardial
border overlapped with endocardial border at valve planes and
at the septum. Hence, RV mass corresponds to the free wall mass
and does not include the septum and trabeculations (Figure 2).
For LV, the endocardial contours excluded papillary muscles
and epicontours included interventricular septum (Prakken
et al., 2008). Once the endo-and epi-contours were traced, end-
diastolic volume (EDV), end-systolic volume (ESV), and mass,
along with functional parameters including ejection fraction
(EF), and stroke volume (SV) were automatically calculated by
the image analysis software for both RV and LV.
Euclycemic Hyperinsulinemic Clamp and M-value
The insulin clamp was performed according to original
description by DeFronzo et al. (1979) after the subjects had fasted
for at least 10 h. A primed-constant insulin (Actrapid 100U ·
mL−1, Novo Nordisk, Bagsvaerd, Denmark) infusion was started
with the rate of 40mU per m2 of body surface area in minute
during the first 4min. Then, the infusion rate was reduced to
20mU per m2 in minute for the time interval 4–7min. After
7min, the infusion rate was further reduced to 10mU per m2
in minute for the rest of the clamp. Exogenous glucose infusion
was started 4min after the start of the insulin infusion with
a rate of [subjects weight (kg) · 0.1]g · h−1. At the 10-min
time point, glucose infusion was doubled and after that further
adjusted according to blood glucose concentration aiming at the
steady level of 5mmol · l−1. Arterialized venous blood samples
were collected before the clamp and every 5min during the first
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FIGURE 2 | An example of tracing the endocontours (orange) and epicontours (light blue) on the RV end-diastolic CMR images from the most apical
slice (A) through slices (B–J) to the most basal slice (K). At the most basal slice (K), the pulmonary valve plane and tricuspid valve plane are excluded according
to instructions by Prakken et al. (2008). As the trabeculations next to the tricuspid valve plane in slice (L) was not visible for the required three phases (figures not
shown), no contours were traced to the slice (L) anymore.
30min of the clamp to determine the glucose concentration for
adjusting the glucose infusion rate. After 30min, blood samples
were taken at every 10min and modification to the infusion
rate were made when necessary. Whole-body insulin stimulated
glucose uptake rate (M-value) was calculated from the glucose
values obtained in the steady state. Thus, M-value is a measure
of whole-body glucose uptake, and it is considered as the most
definitive measure of insulin sensitivity in humans (DeFronzo
et al., 1979).
Maximal Exercise Test (VO2peak)
The subjects performed a maximal exercise test on a cycle
ergometer (Ergoline 800s; VIASYS Healthcare, Germany). The
test started at 50 W and the load was increased by 30 W
at every 2min until exhaustion. Ventilation and gas exchange
was measured (Jaeger Oxycon Pro; VIASYS Healthcare) and
reported as the mean value per minute. The peak respiratory
exchange ratio was ≥ 1.15 and peak blood lactate concentration
immediately and after 1min was ≥ 8.0mmol·l−1 for all subjects.
Also, peak heart rate was within 10 beats of the reference value
(220–age) for all except one subject. The highest 1-min mean
value of oxygen consumption was defined as VO2peak.
Body Composition
Body composition was measured using a bioimpedance monitor
(InBody 720, Mega Electronics Ltd., Kuopio, Finland).
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Statistical Methods
All demographic andmyocardial data inTables 1, 2 are presented
asmean and 95% confidence intervals. Normal distribution of the
variables was tested using Shapiro-Wilk test. Due to non-normal
distribution in RVESV and RVEDV, logarithmic transformations
were done to these variables to achieve normal distribution.
Pairwise correlations are reported as Pearson’s product-
moment correlation coefficients (r). Heatmap (Figure 3) was
produced using heatmap.2 function in “gplots” R-package
with manhattan distance function and Ward’s method for the
agglomeration of the clusters. All variables were centered to zero
mean and scaled to unit variance. Both rows (variables) and
columns (individual subjects) were allowed to be reordered so
that similar variable and individual profiles are shown close to
each other.
Metabolic parameters (RVGU, RVFFAU, LVGU, LVFFAU)
were modeled using lasso regression (Table 3). The least absolute
shrinkage and selection operator, or lasso, is a method for
estimation in linear models introduced by Tibshirani (1996).
Lasso minimizes the sum of squared errors as in typical linear
regression, but in addition it penalizes for the sum of absolute
values of the coefficients. Formally, estimates for coefficients β̂
are achieved by
β̂ = argminβ
(∥∥y − Xβ∥∥2 + λ‖β‖1
)
,
TABLE 1 | Demographic data and whole-body findings for 28 subjects.
Mean 95% Confidence interval
Age (years) 48 (45, 50)
Height (cm) 179 (177, 181)
Weight (kg) 83.6 (80.2, 87.0)
BMI (kg·m−2) 26.1 (25.2, 27.1)
Fat% 22.6 (20.9, 24.2)
HR rest 61 (58, 63)
VO2peak (ml·kg
−1·min−1 ) 34.2 (32.6, 35.8)
M-value (µmol kg−1·min−1 ) (n = 26) 35.3 (29.5, 41.2)
BMI, body mass index; HR rest, heart rate at rest (mean of screening day and two PET
scanning days); VO2peak , peak oxygen consumption during the exercise test; M-value,
whole-body glucose consumption during glucose-insulin clamp.
TABLE 2 | Ventricular parameters for RV and LV.
Right ventricle Left ventricle
n Mean 95% CI n Mean 95% CI
GU (µmol·100g−1·min−1 ) 25 12.1 (10.7, 13.6) 25 46.3 (40.5, 52.1)
FFAU (µmol·100g−1·min−1 ) 24 1.71 (1.50, 1.92) 24 4.22 (3.64, 4.80)
EDV (ml) 27 192 (182, 202) 27 163 (155, 171)
ESV (ml) 27 90.0 (82.9, 97.7) 27 58.0 (53.5, 62.6)
Mass (g) 27 31.8 (30.0, 33.5) 27 122 (115, 130)
EF (%) 27 52.9 (51.0, 54.8) 27 64.6 (63.0, 66.2)
SV (ml) 27 102 (97.5, 106) 27 105 (101, 109)
CI, confidence interval; GU, glucose uptake; FFAU, free fatty acid uptake; EDV, end-
diastolic volume; ESV, end-systolic volume; EF, ejection fraction; SV, stroke volume.
where the first term presents the loss function as in normal
linear regression and the second term stands for penalty, whose
strength is controlled by parameter λ. Because of the penalty
term, some of the coefficients are reduced to zero. The main
advantage of lasso is that it simultaneously performs predictor
selection and produces an interpretable regression model. Hence,
in a final lasso regression model only the predictors having
the strongest effects remain non-zero. Conventionally, the non-
zero coefficients are considered to be the significant predictors
for the model. Since a lasso estimate is a non-linear and non-
differentiable function even for a fixed value of lambda, it is
difficult to calculate accurate estimate for its standard error or its
p-value (Tibshirani, 1996). In the original work, standard error
estimates are obtained by bootstrap resampling. While a test
statistic based on lasso fitted values is proposed (Lockhart et al.,
2014), its R-package “covTest” is described as experimental.
In the present study, lasso modeling was performed using
function glmnet in “glmnet” R-package with parameter alpha
set to 1. The optimal value for penalization coefficient lambda
was determined using repeated cross-validations. The subjects
with missing values (due to technical problems) were excluded
from the lasso models. The datasets used in the lasso models
are relatively small (n = 24 for GU and n = 21 for FFAU).
Obtaining the bootstrap estimates would also require a new
cross-validation procedure in order to find optimal λ for each
sample set. Because of the small study population, such empirical
p-values for the coefficient estimates are not determined in the
present work. Therefore, the regression coefficients obtained in
this work should be interpreted with caution as further study with
larger population is required to verify the results. However, the
strength of the lasso regression over simple pairwise correlations
is that interactions between all the variables are taken into
account simultaneously.
All statistical tests were performed as two-sided with statistical
significance level set at 0.05. The analyses were performed using R
version 3.1.3, the R Foundation for Statistical Computing (http://
www.R-project.org/).
RESULTS
Baseline Statistics
Subject characteristics and whole-body findings are summarized
in Table 1 and parameters describing right and left ventricular
metabolism, structure and function are presented in Table 2. On
average, RV mass and RVGU were roughly 25% of those in LV.
In contrast, FFAU in RV was not so much lower and was 40% of
the FFAU in LV. Both EDV and ESV were somewhat higher in
the RV than in LV, leading to smaller RVEF compared to LVEF.
On the other hand, SV was comparable between LV and RV, as
expected.
Individual Values
Individual values for every measured parameter are visualized
in the heatmap where variables with similar values are clustered
together (Figure 3). As expected, RVGU and LVGU as well as
RVFFAU and LVFFAU are closely related. Interestingly, RVEF
is more closely related to GU whereas LVEF and heart rate
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BMI
Weight
Fat%
LVEDV
LVESV
LV mass
RVSV
LVSV
RV mass
RVEDV
RVESV
Age
VO2peak
M-value
LVGU
RVGU
RVEF
HR
RVFFAU
LVFFAU
LVEF
−2SD
−1SD
mean
+1SD
+2SD
Subjects
FIGURE 3 | A visual presentation of the dataset where each matrix element describes a value for a respective variable (columns) and subject (rows).
Each variable is scaled to zero mean and unit variance. Hence, elements with light colors indicate values close to mean of the given variable, whereas values larger
than mean are presented as red and values smaller than mean as blue matrix elements. The tree on the left side of the matrix describes how variables are related to
each other according to cluster analysis. The shorter the branches are, the stronger the association between the variables is. For example, RVSV and LVSV are tightly
related, as expected. On the other hand, VO2peak, age, and M-value are clustered together but since the branches are longer, the association is not that strong. Dark
gray matrix elements indicate missing values.
TABLE 3 | Lasso regression models for GU and FFAU of both ventricles.
Lasso regression model n RMSE
RVGU = 14.0 − 0.079 · age + 0.025 · RVEF + 0.007·
RVSV
24 3.24
LVGU = 80.4 − 0.757 · age − 0.305 · M-value + 0.241·
RVEF
24 9.78
RVFFAU = −1.20 + 0.036 · LVEF + 0.019 · HR − 0.012·
VO2peak− 0.003 · M-value
21 0.36
LVFFAU = 4.65 + 0.022 · LVEF − 0.398 · log(RVESV) 21 1.27
n, number of subjects used in the model; RMSE, root-mean-square error of the residuals.
associate with FFAU of both ventricles. Age, VO2peak, and M-
value form their own cluster, which is associated with the cluster
of myocardial metabolism and ejection fractions. On the other
hand, all the other parameters related to myocardial structure
and function remain in their own cluster. Weight, BMI, and fat
percent seem to be more closely related to the size of the heart
rather than its metabolism. For instance, subjects with higher
BMI and fat percent often have large-sized heart while their
VO2peak andM-value are decreased. However, individual profiles
vary a lot from subject to subject as can be seen especially in
the middle part of the heatmap where no clear pattern for the
individual parameter profiles emerges.
Pairwise Correlations (GU and FFAU)
RVGU correlated negatively with age (r = −0.43, p = 0.034),
whereas RVFFAU correlated positively with restingHR (r = 0.44,
p = 0.031) and LVEF (r = 0.49, p = 0.018) and negatively
with VO2peak (r = −0.44, p = 0.030), M-value (r = −0.43,
p = 0.045), and LVESV (r = −0.42, p = 0.046). LVGU was
negatively correlated with age (r = −0.54, p = 0.005) and M-
value (r = −0.59, p = 0.002) and positively with RVEF (r = 0.49,
p = 0.015). As expected, correlations between LVGU and RVGU
as well as LVFFAU and RVFFAU were high (r = 0.74, p < 0.001
for GU and r = 0.76, p < 0.001 for FFAU). The only statistically
significant correlation for LVFFAU was with RVESV (r = −0.43,
p = 0.039). The entire correlation matrix for all variables is
shown in Figure 4.
Lasso Regression Results
Myocardial metabolism (RVGU, LVGU, RVFFAU, and LVFFAU)
was modeled using lasso regression model. The variables
included in each model were age, BMI, fat percent, resting HR,
VO2peak, and M-value along with EF, SV, ESV, EDV, and mass
of both ventricles. The obtained lasso regression equations are
presented in Table 3. Considering glucose metabolism, age and
RVEF were significant factors in both ventricles, with younger
age and higher RVEF related to higher GU. For RVGU, RVSV
was also a significant predictor, whereas M-value was a negative
predictor of LVGU. In fatty acid metabolism, LVEF affected
FFAU of both ventricles. In addition, RVFFAU was explained by
resting HR, VO2peak, and M-value while LVFFAU was related
to RVESV. Figures 5, 6 illustrate the order (from left to right)
in which the variables are dropped out or added to the lasso
regression models for RV and LV metabolism, respectively.
DISCUSSION
The first aim of the present study was to investigate the
determinants of the right ventricular glucose and free fatty acid
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FIGURE 4 | Pairwise correlations for all measured variables. The numbers indicate the correlation coefficient for a given pair of variables. Correlations that are
statistically significant (p < 0.05) are highlighted with red (positive correlations) or blue (negative correlations) according to the color key on the right.
metabolism in healthy middle-aged men. The main findings
were that RVGU was predicted by age and RVEF. Interestingly,
RVFFAU was related to VO2peak, resting HR, LVEF, andM-value
which all can be considered as parameters related to physical
fitness and health. The second aim of the study was to compare
the predictors of RV and LV metabolism. As in RVGU, age and
RVEF were also predictors of LVGU. However, the strongest
and negative determinant of LVGU was M-value, which was
not found for RVGU. Another difference between the ventricles
was found in fatty acid metabolism. VO2peak and resting HR
were unique findings only for RVFFAU as these parameters were
not among the strongest predictors for LVFFAU. Interestingly,
ejection fraction was related to myocardial metabolism in such a
way that RVEF was associated to GUwhile LVEF predicted FFAU
of both ventricles. The key findings of the study are summarized
in Figure 7.
Predictors of RV Metabolism
Based on the findings in this study, the strongest predictor
for RVGU was age, implying that RVGU is decreased with
increasing age among middle-aged men. Previous studies have
shown differing results regarding the association between age
and myocardial GU in LV: some report no correlation between
these variables (de Groot et al., 2005; Jeong et al., 2013), while
in other studies GU is decreased in older subjects (Israel et al.,
2007), or even increased in older subjects (Kates et al., 2003).
Also animal studies have shown divergent results in levels of
age-related changes in myocardial glucose transporter isoform 4
(Cartee, 1993; Ozaki et al., 1996; Martineau et al., 1999). Possible
explanations for different results are differences in imaging
protocols (with or without insulin clamp), in quantitative
analyses and also whether subjects were healthy or patients.
However, our result on RVGU supports the statement that the
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FIGURE 5 | The values of lasso regression coefficients as a function of logarithmic lambda for (A) RVGU and (B) RVFFAU. The figures illustrate the order in
which variables are dropped from or added to the model as parameter lambda is increased. Log lambda represents the penalizing factor for the sum of absolute
values of coefficient. The left end of the curves illustrates the coefficients for standard linear regression without any penalty for the number of non-zero coefficients.
When the penalizing factor lambda is increased, increasing number of non-significant variables is reduced to zero. The right end of the curves illustrates hypothetical
maximal penalty where all the coefficients are reduced to zero. Hence, those variables that remain non-zero close to the right end of the curves are the most important
predictors of RVGU or RVFFAU. The optimal log lambda value for each model is determined by repeated cross-validations. The reported lasso regression models in
Table 3 are obtained from the non-zero coefficients at the optimal log lambda values. For example, model for RVGU includes variables age, RVEF, and RVSV, which
are non-zero at optimal log lambda, whereas RV mass is the first term to be left out of the model (reduced to zero before optimal log lambda). The solid lines present
whole-body parameters, dashed lines LV parameters, and dotted lines RV parameters according to the legend on the right.
age seems to affect the myocardial glucose metabolism and
therefore age should be taken into account when performing
measurements of RV myocardial glucose utilization (Peterson
and Gropler, 2010).
Interestingly, the strongest predictors for RVFFAU were
resting HR, VO2peak, LVEF, and M-value which all are related
to physical fitness and health. Negative correlation was found
between RVFFAU and VO2peak and M-value and positive
with resting HR, suggesting that better physical fitness is
related to lower RVFFAU. Previous studies have compared
the fatty acid utilization of the LV between lower and higher
physically active twins (Hannukainen et al., 2007) and between
endurance athletes and sedentary men (Turpeinen et al., 1996;
Takala et al., 1999), and there were no difference in FFAU
between the groups. Furthermore, fatty acid beta-oxidation index
has not been found to be correlated with variables such as
exercise capacity or the size of the heart (Turpeinen et al.,
1996). However, the present study on RV metabolism suggests
that it may be the RVFFAU that is associated with exercise
capacity.
Clustering of the variables in heatmap (Figure 3) revealed
that RV metabolism was related to ejection fraction so that
RVGUwas associated with RVEFwhile RVFFAUwas surprisingly
associated with LVEF. The connection between RVFFAU and
LVEFwas further supported by statistically significant correlation
and by the lasso regression model, where LVEF was the most
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FIGURE 6 | The values of lasso regression coefficients as a function of logarithmic lambda for (A) LVGU and (B) LVFFAU. See the details of the
interpretation in Figure 5 legend.
important factor for RVFFAU (Figures 4, 5). This connection
suggests that there is an important interplay between LV and
RV, in a way that LV function assists that of RV, which is
reflected by its metabolism. While in the present study in
healthy subjects, RVEF was increased with increasing RVGU,
the opposite association has been found in patients with heart
failure or PAH where increased RVGU was related to decrease
of RVEF or other RV functional parameters derived from
echocardiographic measurements (Can et al., 2011; Mielniczuk
et al., 2011; Lundgrin et al., 2013; Yang et al., 2014). This
may reflect different downstream metabolism in health and
disease. In healthy heart, glucose is oxidized to ATP, whereas
in PAH increased GU is associated to increasing portion of
lactate-yielding glycolysis due to disease (Ryan et al., 2015).
Thus, in healthy subjects increased RVEF is likely accompanied
with increase in glucose oxidation while in diseased heart
decreased RV function is associated with increased GU for
glycolysis.
Comparison of RV and LV Metabolism
Common feature for both ventricles was the negative correlation
between GU and age in middle-aged men. Also ejection fraction
was associated with metabolism of both ventricles. An interesting
finding was that RVEF is more closely associated with GU of
both ventricles whereas LVEF was more tightly related to FFAU
of both ventricles. This was supported by all the three analysis
methods used in the study. Such ventricular interdependence
has also been observed in patients with left heart failure, where
RVEF is shown to be stronger predictor of survival than LVEF
(Di Salvo et al., 1995; de Groote et al., 1998; Zornoff et al., 2002).
The statistically significant correlations between RVFFAU and
LVESV as well as between LVFFAU and RVESV further support
the interdependence of the ventricles.
There were two main differences between RV and LV
metabolism. Firstly, only LVGU was inversely related to whole-
body glucose uptake. Similar finding was observed in a previous
study on endurance athletes and sedentary subjects, where the
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FIGURE 7 | Summary of the key findings of the present study on RV
and LV metabolism. Solid lines indicate associations that were confirmed by
both lasso regression model and statistically significant pairwise correlation.
Dashed lines present associations which were confirmed by lasso regression
but pairwise correlations were not statistically significant. The associations
summarized here were also supported by the heatmap (Figure 3). The signs
indicate positive (+) and negative (−) associations.
athletes had enhanced whole-body glucose uptake but reduced
LVGU compared to sedentary subjects (Nuutila et al., 1994).
Interestingly, the present study on sedentary middle-aged men
shows the same association without other confounding factors
such as possible training-induced increase in whole-body insulin
sensitivity or LV hypertrophy. The second difference was the
association between RVFFAU and exercise capacity (VO2peak
and HR rest) which was not found for LVFFAU in these
sedentary middle-aged men. Interestingly, the growing number
of studies have indicated that it is the right ventricle that may
in fact be more important during the exercise, and that its
ejection fraction may be acutely compromised during strenuous
endurance exercise most likely due to the relatively greater
exercise-induced increase in RV work load (Trivax et al., 2010;
La Gerche et al., 2011, 2012; Elliott and La Gerche, 2015). In line
with this, the results obtained in the present study suggest that
particularly the right ventricularmetabolismmay bemore related
to exercise capacity than that of the left ventricle.
Study Limitations
Although lasso regression models for GU and FFAU were
constructed, the models are based on rather small study
population (n = 28) and no separate validation data
was available. However, the results obtained in the presents
study were confirmed by several analyses methods (pairwise
correlations, visualization by heatmap, and lasso regression
model) which supported each other, increasing the validation of
the findings.
GU and FFAU were measured in different metabolic
conditions (GU during insulin clamp and FFAU in the fasted
state) in this study. Therefore, the GU and FFAU rates should
not be directly compared. This selection was done to mimic the
conditions when they both are highest in normal daily life. That
is, after a meal (mimicked with insulin infusion during glucose-
insulin clamp) when GU is highest and in fasted state when FFAU
is highest.
CONCLUSIONS
The glucose utilization of both ventricles was lower in older
subjects. Therefore, age should be taken into account when
measuring myocardial glucose uptake. Interestingly, myocardial
metabolism was found to be associated with ejection fraction and
even so that RVEF was more strongly associated with GU and
LVEF to FFAU of both ventricles, a result showing ventricular
interdependence. The main differences between the ventricles
were that the whole-body glucose uptake was related only to
LVGU, whereas only RVFFAU was related to maximal exercise
capacity and resting heart rate in sedentary middle-aged men.
While the physiologic relevance or mechanism for the findings
of the present study remains unclear, this study highlights the
importance of further study designed specifically on RV as the
results on LV metabolism and physiology may not be directly
applicable to RV.
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